Valuation: Medistim ASA

Market Cap 5.63B 608M 545M 502M 455M 850M 57.9B 864M 5.99B 2.39B 30.3B 2.28B 2.23B 95.98B P/E 2026 *
29.9x
P/E 2027 * 25.5x
Enterprise Value 5.5B 594M 532M 491M 444M 830M 56.55B 844M 5.85B 2.34B 29.6B 2.23B 2.18B 93.74B EV / Sales 2026 *
6.62x
EV / Sales 2027 * 5.88x
Free-Float
69.57%
Yield 2026 *
3.33%
Yield 2027 * 3.49%
1 day-0.32%
1 week+9.25%
Current month+21.34%
1 month+21.83%
3 months+35.84%
6 months+34.65%
Current year+18.53%
1 week 300
Extreme 300
316
1 month 250
Extreme 250
316
Current year 186.5
Extreme 186.5
316
1 year 186.5
Extreme 186.5
316
3 years 130
Extreme 130
316
5 years 130
Extreme 130
402.5
10 years 60
Extreme 60
409
Manager TitleAgeSince
Chief Executive Officer 62 2009-08-31
Director of Finance/CFO - 2000-12-31
Chief Tech/Sci/R&D Officer - 2024-12-31
Director TitleAgeSince
Chairman 78 1999-12-31
Director/Board Member 49 2013-12-31
Director/Board Member 56 2023-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
3/4/25 Buy

Chairman

860,735 4.6939%
1/27/25 Buy

Chairman

45,000 0.2454%
1/9/25 Buy

Chairman

30,000 0.1636%
Change 5-day change 1-year change 3-year change Capi.($)
-0.32%+9.25%+10.43%+61.58% 608M
+0.28%+4.59%+26.74%+62.99% 260B
+0.66%+2.70%+10.26%+27.48% 165B
+0.74%+1.05%-16.57%+73.51% 154B
-1.17%-8.45%-58.01%-15.84% 61.49B
+2.80%+5.03%+14.43%+51.74% 52.9B
+0.70%+2.71%-13.09%-6.29% 52.84B
-1.73%-3.37%+8.73%+63.81% 51.46B
-0.32%+4.12%+26.43%+78.96% 51.16B
+0.62%+5.40%+39.81%+102.87% 46.85B
Average +0.20%+1.94%+4.92%+50.08% 89.63B
Weighted average by Cap. +0.39%+1.41%+7.00%+51.16%

Financials

2026 *2027 *
Net sales 831M 89.68M 80.33M 74.11M 67.06M 125M 8.54B 127M 884M 353M 4.47B 337M 329M 14.16B 938M 101M 90.67M 83.65M 75.7M 142M 9.64B 144M 998M 398M 5.05B 380M 372M 15.98B
Net income 189M 20.4M 18.27M 16.86M 15.25M 28.52M 1.94B 28.98M 201M 80.22M 1.02B 76.55M 74.92M 3.22B 221M 23.85M 21.36M 19.71M 17.84M 33.35M 2.27B 33.89M 235M 93.81M 1.19B 89.51M 87.6M 3.76B
Net Debt -132M -14.19M -12.71M -11.73M -10.61M -19.84M -1.35B -20.17M -140M -55.82M -707M -53.26M -52.13M -2.24B -118M -12.68M -11.36M -10.48M -9.48M -17.73M -1.21B -18.02M -125M -49.87M -632M -47.59M -46.58M -2B
Projected Income Statement - Annual - Medistim ASA
Logo Medistim ASA
Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The Company provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
Employees
159
Date Price Change Volume
26-10-29 NOK 307.00 -0.32% 9,162
26-10-28 NOK 308.00 +0.65% 45,011
26-10-27 NOK 306.00 -0.65% 27,852
26-10-26 NOK 308.00 +2.67% 43,679
26-10-23 NOK 300.00 +6.76% 89,951
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Medistim ASA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
308.00NOK
Average target price
365.00NOK
Spread / Average Target
+18.51%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medistim ASA
  1. Stock Market
  2. Stocks
  3. MEDI Stock